Kathleen Skarvan sold $2.3M of ELMD
director at Electromed, Inc.. 76,583 shares at an average of $30.48, traded Feb 14, 2025, filed Feb 19, 2025.
Score components
- +15RoleDirector
- +25Trade size$2.3M at market
- +20Share of holdings soldSold 95% of holdings
- +8Cluster2 insiders selling within 14 days
- +10Role exitThe filing reports the insider leaving
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.8%, 3m -28.9%, 6m -33.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-25-004433, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 14, 2025 | MOption exercise Common Stock | +40,000 | $1.80 | $72k | 95,394 | Feb 19, 2025 |
| Feb 14, 2025 | FTax withholding Common Stock | -15,178 | $33.21 | $504k | 80,216 | Feb 19, 2025 |
| Feb 14, 2025 | SOpen-market sale Common Stock | -7,558 | $32.13 | $243k | 72,658 | Feb 19, 2025 |
| Feb 14, 2025 | SOpen-market sale Common Stock | -1,082 | $33.08 | $36k | 71,576 | Feb 19, 2025 |
| Feb 14, 2025 | SOpen-market sale Common Stockindirect: By Trust | -23,989 | $32.07 | $769k | 5,000 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: By Trust | -5,000 | $29.15 | $146k | 0 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stock | -38,954 | $29.28 | $1.1M | 32,622 | Feb 19, 2025 |
| Feb 14, 2025 | MOption exercise Employee Stock Option (right to buy)derivative | -40,000 | $0.00 | $0 | 0 | Feb 19, 2025 |
Related signals
Other insiders at Electromed, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Electromed, Inc. | James L. Cunniff CEO and President | $354k 9,700 shares | -6% | |
| 42Moderate | Electromed, Inc. | Bradley M. Nagel Chief Financial Officer | $429k 11,801 shares | -38% | |
| 45Moderate | ELMDsell Electromed, Inc. | Kathleen Skarvan director | $1.4M 40,000 shares | -53% | |
| 60Notable | ELMDsell Electromed, Inc. | Andrew Summers director | $1.6M 65,714 shares | -100% | |
| 58Moderate | Electromed, Inc. | Andrew Summers director | $3.1M 111,475 shares | -37% | |
| 45Moderate | ELMDsell Electromed, Inc. | Andrew Summers director | $1.1M 37,404 shares | -12% | |
| 53Moderate | Electromed, Inc. | Andrew Summers director | $2.0M 65,630 shares | -19% | |
| 78Notable | Electromed, Inc. | Kathleen Skarvan director | $4.2M 150,000 shares | -103% | |
| 46Moderate | ELMDbuy Electromed, Inc. | James L. Cunniff CEO and President | $137k 9,000 shares | +900% | |
| 36Weak | ELMDbuy Electromed, Inc. | Andrew Summers director | $302k 28,797 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.